Wordt geladen...
Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom
Respiratory syncytial virus (RSV) infection produces more severe disease and increased hospitalization rates in high-risk babies. The monoclonal antibody palivizumab offers protection against complications, and the first of five monthly doses should be administered before the onset of community RSV...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cambridge University Press
2007
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2870551/ https://ncbi.nlm.nih.gov/pubmed/16753078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268806006601 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|